Breast cancer type and bone scan patterns study
Part of Cancer, Skin clinical trials.
This study looks at how different types of breast cancer spread to the bones, using bone scans. It may help doctors better understand and predict bone metastasis based on your cancer's specific characteristics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer, either invasive ductal, invasive lobular, or another type.
- You are between 18 and 80 years old.
- You have had a biopsy or surgery that identified your cancer's molecular subtype (such as luminal A, luminal B, HER2-positive, or triple-negative).
- You are scheduled for a bone scan as part of your initial staging, follow-up, or because your doctor suspects the cancer has spread to your bones.
- You do not have any other type of cancer, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at medical records from breast cancer patients to create a tool that can better predict if and when the cancer might spread to the bones. By understanding these patterns, doctors may be able to catch bone metastases earlier and improve treatment plans.
This trial aims to find out if doing special scans to check for breast cancer spread to organs (not just lymph nodes) is helpful in certain patients. The study looks at people with breast cancer that had already spread to lymph nodes and did not completely go away with chemotherapy and surgery.
This trial checks whether specific “surveillance” markers (measured from blood and bone marrow) can help predict if breast cancer comes back after standard treatments. It may help doctors monitor you more accurately and earlier if recurrence risk is high.
This trial looks at tumor cells in the blood of women with breast cancer to understand them better. It may help doctors learn more about how the disease spreads.
This study tests whether regular brain scans (surveillance) help spot brain metastases early in people with HER2-positive breast cancer that has spread to other parts of the body. Participation involves being randomly assigned to either routine brain scans or no extra scans to see which approach is better.
This study uses a CT scan to estimate how strong a cancer-affected bone area is, helping doctors evaluate fracture risk and bone management. It is aimed at adults with bone lesions from several common cancer types.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.